Effect of Hydrodynamic Environment on Tablets Dissolution Rate

Pharmaceutical Development and Technology

Volumn 9, Issue 1, 2004, Pages 25-37

  Wu, Yan ^a   Kildsig, D O ^b   Ghaly, E S ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Diffusion; Dissolution; Dissolution model; Hydrodynamic condition; Mass transfer; Naproxen; Theophylline; USP 1; USP 2

Indexed keywords

NAPROXEN; THEOPHYLLINE;

ARTICLE; DIFFUSION; DISSOLUTION; DRUG DOSAGE FORM; DRUG RELEASE; DRUG SOLUBILITY; FILM; HYDRODYNAMICS; INTERMETHOD COMPARISON; PRIORITY JOURNAL; ROTATION; SURFACE PROPERTY; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET HARDNESS; TABLET MANUFACTURE; TABLET PROPERTY; TABLET SURFACE; TABLET THICKNESS; VELOCITY;

CHEMISTRY, PHARMACEUTICAL; ENVIRONMENT; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL; WATER;

EID: 1342344166     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-120027415     Document Type: Article

References (26)

1. Brock, M.H.; Dansereau, R.J.; Patel, V.S. Use of in vitro and in vivo data in the design, development, and quality control of sustained-release decongestant dosage forms. Pharmacotherapy 1994, 14, 430-437.
2. Drewe, J.; Guitard, P. In vitro/in vivo correlation for modified-release formulations. J. Pharm. Sci. 1993, 82, 132-137.
3. Uppor, V.R. Regulatory perspectives in in vitro (Dissolution) in vivo (bioavailability) correlations. J. Control. Release 2001, 72, 127-132.
4. Murthy, K.S.; Ghebre-Sellassie, I. Current perspectives on the dissolution stability of solid oral dosage forms. J. Pharm. Sci. 1993, 82, 113-126.
5. Quist, P.O.; Ostling, G. Accelerated dissolution testing for improved quality assurance. J. Pharm. Biomed. Anal. 2002, 28, 1081-1089.
6. Qureshi, S.A.; McGilvery, I.J. Assessment of pharmaceutical quality of furosemide tablets from multinational markets. Drug Dev. Ind. Pharm. 1998, 24, 995-1005.
7. Dressman, J.B.; Reppas, C. In vitro in vivo correlation for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci. 2000 (Suppl 2), S73-S80.
8. Rostami-Hodjegan, A.; Shira, M.R.; Tucker, G.T.; Conway, B.R.; Irwin, W.J.; Shaw, L.R.; Grattan, T.J. A new rapidly absorbed paracetamol tablet containing sodium bicarbonate. II. Dissolution studies and in vitro/in vivo correlation. Drug Dev. Ind. Pharm. 2002, 28, 533-543.
9. Kortejarvi, H.; Mikkola, J.; Backman, M.; Antila, S.; Marvola, M. Development of level A, B, and C in vitro in vivo correlation for modified-release levosimendan capsule. Int. J. Pharm. 2002, 24, 87-95.
10. Roshdy, M.N.; Schnaare, R.L.; Sugita, E.T.; Zietz, S.; Schwartz, J.B. An adjusted pharmacokinetic equation for predicting drug levels in vivo based on in vitro square root of time release kinetics. Pharm. Dev. Technol. 2002, 203-213.
11. Roshdy, M.N.; Schnaare, R.L.; Sugita, E.T.; Schwartz, J.B. The effect of controlled release tablet performance and hydrogel strength on in vitro/in vivo correlation. Pharm. Dev. Technol. 2002, 7, 155-168.
12. Horter, D.; Dressman, J.B. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliv. Rev. 2001, 46, 75-87.
13. Dali, M.V.; Carstensen, J.T. Particle size distribution from multi-particulate dissolution. Drug Dev. Ind. Pharm. 1998, 24, 637-644.
14. Shah, V.P.; Gurbarg, M.; Noory, A.; Dighe, S.; Skelly, J.P. Influence of higher rates of agitation on release patterns of immediate-release drug products. J. Pharm. Sci. 1992, 81, 500-5003.
15. Kamba, M.; Seta, Y.; Takeda, N.; Hamaura, T.; Kusai, A.; Nakane, H.; Nishimura, K. Measurement of agitation force in dissolution test and mechanical destructive force in disintegration test. Int. J. Pharm. 2003, 250, 99-109.
16. Morihara, M.; Aoyaji, N.; Kaniwa, N.; Katori, N.; Kojim, S. Hydrodynamic flow around tablets in different pharmacopeial dissolution tests. Drug Dev. Ind. Pharm. 2002, 28, 655-662.
17. Underwood, F.L.; Cadwallader, D.E. Effects of various hydrodynamic conditions on dissolution rate determinations. J. Pharm. Sci. 1976, 65, 697-700.
18. Cartensen, J.T.; Dali, M. Determination of mass transfer dissolution rate constants from critical time of dissolution of a powder sample. Pharm. Dev. Technol. 1999, 4, 1-8.
19. Healy, A.M.; McCarthy, L.G.; Gallagher, K.M.; Corrigan, O.I. Sensitivity of dissolution rate to location in the paddle dissolution apparatus. J. Pharm. Pharmacol. 2002, 54, 441-444.
20. Pillay, Y.; Fassihi, R. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. J. Control. Release 1998, 55, 45-55.
21. Bhattachar, S.N.; Wesley, J.A.; Fioritto, A.; Martin, P.J.; Babu, S.R. Dissolution testing of poorly soluble compound using the flow-through cell dissolution apparatus. Int. J. Pharm. 2002, 236, 135-143.
22. Cappola, M.L. A better dissolution method for ranitidine tablets USP. Pharm. Dev. Technol. 2001, 6, 11-17.
23. Shaw, L.R.; Irwin, W.J.; Grattan, T.J.; Conway, B.R. The development of a modified dissolution method suitable for investigating powder mixtures. Drug Dev. Ind. Pharm. 2002, 28, 1147-1153.
24. Mulder, H.; Brere, A.M.; Van Adel, J.G.; Rulkens, W.H. Influence of hydrodynamic conditions on napthalene dissolution and subsequent biodegradation. Biotechnol. Bioeng. 1998, 57, 145-154.
25. Grassi, M.; Colombo, I.; Lapasin, R. Experimental determination of the theophylline diffusion coefficient in swollen sodium-alginate membranes. J. Control. Release 2001, 76 (1-2), 93-105.
26. Pade, V.; Stavchansky, S. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drug in the Caco-2 cell culture model. 1997, 14 (9), 1210-1215.